Respiratory Syncytial Virus (RSV) Vaccine - Recombinant
Why is it prescribed?
The RSV vaccine is indicated for use in adults 60 years of age and older for the prevention of lower respiratory tract disease caused by RSV.
Products that have this ingredient include •Arexvy vaccine •
See other drugs used in the treatment of •Respiratory Syncytial Virus (RSV) •
Very common: pain at the injection site, tiredness, headache, muscle pain
Common: redness and swelling at the injection site, fever, chills, runny nose
Uncommon: injection site itching, pain, generally feeling unwell, swelling of lymph nodes, rash, nausea, stomach pain
The RSV vaccine helps the body make antibodies and white blood cells that fight against the RSV-A or RSV-B subtypes in adults aged 60 years and older. The RSV virus can can cause severe influenza-like illness and lower respiratory tract illness in some people.
Do not get this vaccine if you have:
- had previous life-threatening allergic reaction to any component of the vaccine (check with your health care provider for vaccine ingredients)
- a serious illness with a high temperature. A minor infection such as a cold, including mild fever, should not require you to postpone the vaccination.